Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP01 lozenges for cough due to URTI
NCT01597349Phase 2Completed
- Sponsor
- Avalo Therapeutics
- Start
- May 2012
- Primary completion
- Sep 2012
- Countries
- 2
01
Overview
A Phase 2 trial of memantine lozenge FP01 in cough, sponsored by Avalo Therapeutics. Started May 2012; status: completed.
02
Drugs
memantine lozenge FP01
03
Conditions
cough
Beyond the preview
Go deeper on NCT01597349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01597349.